What question did this study set out to answer?

This study aims to evaluate the efficacy and safety of efgartigimod in treating juvenile myasthenia gravis (JMG).

March 10, 2026Muscle & Nerve0 citations

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study

Key Points

This study aims to evaluate the efficacy and safety of efgartigimod in treating juvenile myasthenia gravis (JMG).
Retrospective analysis across multiple centers in China
Assessment of efficacy and safety profiles of efgartigimod
Inclusion of pediatric patients diagnosed with JMG
Efgartigimod demonstrated favorable efficacy in treating JMG
The safety profile was also found to be acceptable
Further studies are required to solidify these findings in the pediatric demographic

Abstract

Our study suggests efgartigimod is an effective therapeutic option for JMG, with favorable efficacy and safety profiles. Further studies are necessary to validate the efficacy and safety of efgartigimod in the pediatric population.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Lin et al. (Sat,) studied this question.

synapsesocial.com/papers/69af957570916d39fea4d0f0 https://doi.org/https://doi.org/10.1002/mus.70202

AI से पूछें

Bookmark

View Full Paper